Characteristic | Grade/ Score | Overall Sample | Any-Amputation | Major-Amputation | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Non Amputees (n = 162, 68.4%) | Amputees* (n = 75, 31.6%) | Non Amputees (n = 208, 87.8%) | Amputees (n = 29, 12.2%) | ||||||||
Proportion | Frequency (n = 237) | Proportion | n | Proportion | n | Proportion | n | Proportion/ Mean | n | ||
Gender | Female | 16.46% | 39 | 12.24% | 29 | 4.22% | 10 | 14.77% | 35 | 1.69% | 4 |
Male | 83.54% | 198 | 56.12% | 133 | 27.43% | 65 | 73% | 173 | 10.55% | 25 | |
Age, years (mean) | – | 65.91 (SD 12.3) | 237 | 64.59 (SD 12.8) | 162 | 68.76 (SD 10.5) | 75 | 65.55 (SD 12.5) | 208 | 68.52 (SD 12.4) | 29 |
PEDIS Sum (mean) | – | 10.76 (SD 1.9) | 237 | 10.27 (SD 1.9) | 162 | 11.81 (SD 1.4) | 75 | 10.56 (SD 1.9) | 208 | 12.17(SD 1.4) | 29 |
Perfusion | Stage 1 | 48.1% | 114 | 40.93% | 97 | 7.17% | 17 | 45.57% | 108 | 2.53% | 6 |
Stage 2 | 32.49% | 77 | 20.25% | 48 | 12.24% | 29 | 27.85% | 66 | 4.64% | 11 | |
Stage 3 | 19.41% | 46 | 7.17% | 17 | 12.24% | 29 | 14.35% | 34 | 5.06% | 12 | |
Extent | Stage 1 | 3.38% | 8 | 3.38% | 8 | 0% | 0 | 3.38% | 8 | 0% | 0 |
Stage 2 | 31.22% | 74 | 28.27% | 67 | 2.95% | 7 | 30.38% | 72 | 0.84% | 2 | |
Stage 3 | 65.4% | 155 | 36.71% | 87 | 28.69% | 68 | 54.01% | 128 | 11.39% | 27 | |
Depth | Stage 1 | 5.91% | 14 | 5.06% | 12 | 0.84% | 2 | 5.91% | 14 | 0% | 0 |
Stage 2 | 32.91% | 78 | 28.27% | 67 | 4.64% | 11 | 31.65% | 75 | 1.27% | 3 | |
Stage 3 | 61.18% | 145 | 35.02% | 83 | 26.16% | 62 | 50.21% | 119 | 10.97% | 26 | |
Infection | Stage 1 | 36.29% | 86 | 26.16% | 62 | 10.13% | 24 | 33.76% | 80 | 2.53% | 6 |
Stage 2 | 35.44% | 84 | 22.78% | 54 | 12.66% | 30 | 29.54% | 70 | 5.91% | 14 | |
Stage 3 | 25.74% | 61 | 18.14% | 43 | 7.59% | 18 | 22.78% | 54 | 2.95% | 7 | |
Stage 4 | 2.53% | 6 | 1.27% | 3 | 1.27% | 3 | 1.69% | 4 | 0.84% | 2 | |
Sensation | Stage 1 | 7.17% | 17 | 5.49% | 13 | 1.69% | 4 | 6.75% | 16 | 0.42% | 1 |
Stage 2 | 92.83% | 220 | 62.87% | 149 | 29.96% | 71 | 81.01% | 192 | 11.81% | 28 |